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PACAP (pituitary adenylate cyclase-activating polypeptide) is a member of the VIP/secretin/glucagon family, which includes the ligands of
class II G-protein coupled receptors. Since the recognition of PACAP by the receptor may involve the binding of PACAP to membranes, its
membrane-bound structure should be important. We have carried out structural analysis of uniformly 13C,15N labeled PACAP27 and its C-terminal
truncated form PACAP(1–21)NH2 (PACAP21) bound to membranes with high resolution solid-state NMR. Phosphatidylcholine bilayers and
phosphatidylcholine/phosphatidylglycerol bilayers were used for PACAP27 and PACAP21, respectively. Most backbone signals were assigned for
PACAP27 and PACAP21. TALOS analysis revealed that both peptides take on extended conformations on the membranes. Dilution of PACAP21
did not change the conformation of the major part. Selective polarization transfer experiment confirmed that PACAP27 is interacting with the
membranes. It was concluded that the interaction of PACAP with the membrane surface causes their extended conformation. PACAP27 is reported
to take an α-helical conformation in dodecylphosphocholine micelles and membrane-binding peptides usually take similar conformations in
micelles and in membranes. Therefore, the property of PACAP27 changing its conformation in response to its environment is unique. Its
conformational flexibility may be associated with its wide variety of functions.
© 2007 Elsevier B.V. All rights reserved.Keywords: Pituitary hormone; PACAP27; Membrane-bound peptide; Isotope-labeling; NMR signal assignment; Extended conformation1. Introduction
PACAP (pituitary adenylate cyclase-activating polypeptide)
is a hormone peptide classified into VIP/secretin/glucagon
family, which are ligands of class II G-protein coupled receptors.
This peptide was first isolated from ovine hypothalamus, which
directly stimulates the release of several pituitary hormones.Abbreviations: CP, cross-polarization; DARR, dipolar assisted rotational
resonance; DMPC, 1,2-dimyristoyl-sn-glycero-3-phosphocholine; DPPC, 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine; DPPG, 1,2-dipalmitoyl-sn-glycero-
3-phosphatidylglycerol; DSS, 2,2-dimethylsilapenatane-5-sulfonic acid; LGCP,
Lee–Goldburg cross polarization; PACAP, pituitary adenylate cyclase-activat-
ing polypeptide; RFDR, radio-frequency-driven recoupling; SPC-5, five-step
super phase cycle; TPPM, two-pulse phase modulation; trNOE, transferred
nuclear Overhauser effect; VIP, vasoactive intestinal polypeptide
⁎ Corresponding author. Fax: +81 6 6872 8219.
E-mail address: akutsu@protein.osaka-u.ac.jp (H. Akutsu).
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doi:10.1016/j.bbamem.2007.10.015Two forms of PACAP, which are composed of 27 and 38 amino
acid residues, have been found, and are called PACAP27 and
PACAP38, respectively. The amino acid sequence of the former
is identical to that of the N-terminal 27 residues of the latter.
PACAP is evolutionally conserved in vertebrates. The primary
structure of PACAP38 has been totally conserved among human
[1], sheep [2], rat [3], and mouse [4]. The sequences of PACAP38
and PACAP27 are shown below along with a C-terminal trun-
cated derivative, PACAP21.
PACAP38 HSDGIFTDSYSRYRKQMAVKKYLAAVLGK-
RYKQRVKNK-NH2
PACAP27 HSDGIFTDSYSRYRKQMAVKKYLAAVL-NH2
PACAP21 HSDGIFTDSYSRYRKQMAVKK-NH2
The sequence of PACAP has been determined for several
non-mammalian vertebrates and invertebrates, including chick-
en Galus domesticus [5], frog Rana ridibunda [6], salmon
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tunicate Chelyosoma productum [9]. There is 96% sequence
identity between human and tunicate PACAP27 [9]. These facts
suggest that there have been a high evolutionary pressure to
conserve the PACAP sequence.
In view of the sequence homology, the mechanism underlying
the binding of PACAP to its receptor should be fundamentally
conserved as well. The PACAP receptors are classified into 3
subtypes, i.e. PAC1, VPAC1 and VPAC2. PAC1 is involved in
several neurotransduction systems, and is found in brain areas,
including the hypothalamus. Therefore, PACAP might be
working as neurotransmitter/neuromodulator and hypophysio-
tropic neurohormone regulator [10–12]. PACAP receptors are
located not only in the brain, but also in peripheral tissues. VPAC1
and VPAC2, which serve as high affinity receptors for both
PACAP and VIP, are primarily coupled with adenylate cyclase in
the human muscle, heart, lung, kidney, stomach, testis, pancreas,
and liver. This peptide acts as a blood pressure depressor [13], a
smooth muscle relaxing factor [14], a promotion factor of insulin
release from the pancreatic β-cell, and so on [15]. Thus, PACAP
plays important roles in various physiological regulation systems.
The tertiary structures of PACAP21 bound to the PAC1 re-
ceptor and PACAP27 in dodecylphosphocholine (DPC) micelles
were determined by transferred nuclear Overhauser effect
(trNOE) and steady-state NOE, respectively [16]. The structure
of micelle-bound PACAP27 comprises a long α-helix (residues
5–27) flanked by a disordered N-terminal tail (residues 1–4). In
the case of the receptor-bound PACAP21 structure, however, an
extended N-terminal tail (residues 1–2) is followed by conse-
cutive β-turns (residues 3–7) and an α-helix (residues 8–21). A
two-step model for the ligand targeting to the receptor through
the membrane surface was proposed on the basis of the obtained
conformations. Recently, the solution structure of N-terminally
truncated PACAP38 (residue 6–38) binding to the extracellular
domain of the PAC1 receptor was determined by NMR [17]. The
peptide takes on a curved α-helix in the receptor.
Since the recognition of PACAP by the receptor and the
following signal transduction take place in the membrane
systems and a model for the recognition mechanism involves
membrane-binding of PACAP, it is important to know the
conformations of PACAP27 bound to membranes. For the
analysis of the membrane-bound peptide, solid-state NMR is
one of the most suitable methods. We have actually shown
that this is a promising method through the structural analysis
of a G-protein activating peptide, mastoparan X [18,19] and
H+-ATPsynthase subunit c [20]. Conformational studies of
other membrane-bound peptides have been reported as well [21].
The results reported so far have revealed that many of them take
on α-helices in their major parts. Usually, it is not easy to obtain
uniformly isotope labeled peptides for NMR analysis. We have
developed an efficient expression system for PACAP peptides.
Then, the structural analysis of membrane-bound PACAP
peptides by solid-state CP/MAS NMR has been carried out in
this work. The result has shown that the conformations of the
membrane-bound peptides are different from that of the micelle-
bound one and PACAP peptides assume different conformations
depending on the interacting partners.2. Materials and methods
2.1. Peptide expression and purification
ApET21b vector was used to clone a gene of the fusion protein of thioredoxin
(Trx) and PACAP21-Gly or PACAP27-Gly with an N-terminal 6His-tag [22]. It
was introduced into competent Escherichia coli (E. coli) BL21 (DE3) (Novagen,
Madison, WI, USA) and expressed under the control of lac promoter. A single
colony was inoculated into 5 ml of LB medium containing ampicillin (50 μg/ml)
and it was incubated for 3–5 h at 37 °C. When OD660 became 0.5, 1 ml of the
culture was inoculated into 500 ml of CHL medium (CHLORELLA Industry
Co., Tokyo, Japan) with ampicillin (50 μg/ml) in a 2-l baffled flask, which was
incubated for about 4 h at 37 °C with a shaking rate at 120 rpm. At 0.2 OD660, the
temperature was adjusted to 30 °C. At 0.5 OD660, isopropylthio-β-D-galactoside
(IPTG) was added (final 0.8 mM) for induction. The cells were further incubated
for 6 h (up to about 1 OD660) and harvested. The cell suspension was sonicated
for 10 min (2 min interval per min) at 4 °C and was centrifuged for 20 min at
20000 rpm. The supernatant was applied to a DEAE column. Then, the fusion
protein was purified by Ni-NTA superflow (Qiagen, Valencia, CA, USA) affinity
column chromatography at 4 °C and was concentrated. For isotope-labeling, 1 ml
culture at OD660=0.5 was centrifuged at 6000 rpm. The pellet was suspended
with 0.1 ml of a 0.9% NaCl solution, and added to 500 ml of a 13C,15N labeled
CHL medium.
For cleavage of the fusion protein, Factor Xa (NewEnglandBiolabs, Beverly,
MA, USA)was added at 0.25% (w/w) of the substrate in a 100mMNaCl, 50mM
Tris–HCl buffer, pH 7.4. The substrate concentration was about 0.6 mM. The
reactionmixture was incubated for 3 h at 4 °C. The Factor Xawas removedwith a
Sep-Pak C18 environmental cartridge (Waters, Milford, MA, USA). The
PACAP21-Gly or PACAP27-Glywas eluted with acetonitrile solution (50–70%)
containing 0.05% (v/v) TFA, then purified by reverse-phase HPLC (Gilson,
Middleton, WI, USA) with a Wakosil 5C18 column (Wako Pure Chemical
Industries, Ltd, Osaka, Japan) and a linear water/acetonitrile gradient containing
0.05% TFA.
C-terminal amidation of the obtained peptide was achieved by the oxidation
of its terminal Gly residue with peptidylglycine α-amidating enzyme [23]. The
purified PACAP was obtained with the HPLC again. The purities of these
peptides were confirmed by Tricine-SDS-PAGE and mass spectrometry using a
matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass
spectrometer (Autoflex, Bruker Daltonics, Germany). Peptidylglycine amidating
monoxygenase was purchased fromWako Pure Chemical Industries, Ltd (Japan).
2.2. Preparation of membrane-bound peptides
Multilamellar liposomes were prepared by a freeze-and-thaw treatment. For
PACAP21, deuterated 1,2-dipalmitoyl-sn-glycero-3-phosphocholine-d62
(DPPC, 98% 2H) and deuterated 1,2-dipalmitoyl-sn-glycero-3-phosphogly-
cerol-d62 (DPPG, 98%
2H) were used to prepare liposomes. They were dissolved
in chloroform/methanol (1:1, v/v), and then the solution was dried to a film by
evaporator. The ratio of DPPC to DPPGwas 4 to 1 (mol/mol). It was further dried
under high vacuum to remove all trace of organic solvent. The dried film was
suspended in ultrapure water. The final concentration of the suspension was
10mg/ml. The lipid suspensionwas subjected to typically ten freeze/thaw cycles.
For PACAP27, deuterated 1,2-dimyristoyl-sn-glycero-3-phosphocholine-d54
(DMPC, 98% 2H) was used as the phospholipid. Then, the peptide was
added to the liposome suspension (lipid/PACAP21=36 and 360, and lipid/
PACAP27=20 mol/mol), followed by about ten freeze/thaw cycles. The
supernatant was removed by centrifugation at 30000 g for 30 min. DMPC-d54,
DPPC-d62, and DPPG-d62 were purchased from Cambridge Isotope Laboratories
Inc. (Andover,MA,USA). The liposomeswith peptideswere once dried and then
hydrolyzed under 32% relative humidity. The samples of PACAP21 (3.8mg) and
PACAP27 (4 mg) were transferred to 4 mm and 3.2 mm rotors, respectively.
2.3. Solid-state NMR spectroscopy
NMR measurements were performed with Varian Infinity-plus 500, 600 and
700 spectrometers (Palo Alto, CA, USA) operating at 11.74, 14.09 and 16.44 T
static magnetic fields, respectively. Broadband double and triple resonance
MAS probes for the sample rotors with 3.2 and 4 mm diameters were used. The
Fig. 1. 2D 13C–13C correlation DARR spectra of membrane-bound [U–13C, 15N] PACAP21 at 11.74 Tand 223 K. DARRmixing time, 9 ms for A, C and D, and 200ms for B;
number of acquisition, 64 for each FID; andMAS frequency (ωR)=12.5 kHz. (A) aliphatic-carbonyl carbon correlation, (B)Arg and Tyr region, (C) Cβ-aromatic Cγ correlation,
and (D) aliphatic carbon correlation. The side-chain connectivity was indicated with solid lines for Ile, Thr, Val, Arg, and Lys. Sensitivity is enhanced in the squared region.
Fig. 2. 2D intra- and inter-residue 15N–13C correlation spectra of membrane-
bound [U–13C, 15N] PACAP21 at 213 K. (A) Intra-residue 15N–13C correlation
at 14.09 T. Contact time from Ni to Ci, 4 ms; number of acquisition, 64 for each
FID; data matrix, 512 (t1)×400 (t2); and ωR=16 kHz. (B) Inter-residue
15N–13C correlation at 11.74 T. Contact time from Ni+1 to C'i, 4 ms; DARR
mixing time, 24 ms; number of acquisition, 60 for each FID; data matrix,
512×300; and ωR=12.5 kHz.
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273 K. The 1H radio frequency (RF) amplitude was 70 kHz for TPPM
decoupling [24]. Lee–Goldburg cross-polarization experiment [25], two-
dimensional 13C homonuclear correlation experiment RFDR [26,27], SPC-5
[28] and DARR [29,30] were recorded with standard pulse sequences. The 1H
RF amplitude for DARR was 12.5 kHz. Heteronuclear correlation experiments
(intra-residue 15Ni-(
13Cα13Cβ)i correlation and inter-residue
15Ni+1-(
13Cα13Cβ)i
correlation) and (13Cα13Cβ)i-(
13Cα13Cβ)i+1 experiment were performed using
reported pulse sequences [18]. The initial magnetization was prepared by cross
polarization from the proton magnetization with a contact time of 2 ms and the
RF field amplitude was ramped near the first sideband for the Hartmann–Hahn
condition, γBX1=γB
H
1−ωR. Here, γBX1 and γBH1 are the RF field amplitudes
of 13C and 1H respectively and ωR is the sample spinning frequency. Frequency
selective CP from 15N to 13C was used in 15N–13C correlation experiments
[31,32]. Data matrix (512 (t1)×1024 (t2), unless otherwise mentioned) was
zerofilled to 1024×1024, multiplied by an exponential window function with a
100 Hz broadening factor, and analyzed with the aid of Felix version 2002
(Accelrys Inc., San Diego, CA USA). All two-dimensional spectra were
presented by the contours with S/NN3.0 except for otherwise specified. 13C and
15N chemical shift values were referenced to 2,2-dimethylsilapenatane-5-
sulfonic acid (DSS) [33].
13C NMR observation of 2H/31P-selective 1H-depolarization under magic
angle spinning (COXSHD) was carried out at 11.74 T according to the reported
method [34]. The RF phase for the depolarization period was alternated at the
intervals of 240 and 160 μs for 2H and 31P, respectively. The 1H depolarization
was facilitated by the phase-alternating cross polarization. The flip angles of all
the 1H pulses are 54.7°. The B1 field amplitudes satisfy the condition mentioned
above at the spinning rate of 12.5 kHz. The BX1 amplitudes for
2H and 31P were
31 and 52 kHz, respectively. The frequency of BX1 was shifted by about
130 kHz under the off Hartmann–Hahn condition. Contact time for 13C–1H
LGCP was 80 μs. The 1H RF amplitude was 70 kHz. The 16,000 transients were
accumulated at 193 K.
3. Results
3.1. Signal assignment of PC/PG-membrane bound PACAP21
Since PACAP21 did not bind to PC bilayers, DPPC/DPPG
bilayers were used as membranes. To suppress the background
signals from the lipids, deuterated DPPC-d62 and DPPG-d62were used for sample preparation. The assignment of the signals
was carried out as follows. At first, the type of amino acid was
determined, using intra-residual 13C,13C- and 13C,15N- corre-
lation spectra. The sequential number can be identified for
single residues in the peptide at this stage. Then, the sequential
assignment was performed using inter-residual 13Ci,
15Ni+1- and
13Ci,
13Ci+1-correlation 2D NMR spectra. Here, some of the
signals were unequivocally assigned. Then, the overlapped
Fig. 3. A 2D inter-residue (CαCβ)i–Cαi+1 correlation spectrum of membrane-
bound [U–13C, 15N] PACAP21 at 11.74 T and 213 K. Contact times from Ci+1 to
Ni+1 and from Ni+1 to C'i, 2.5 and 4 ms, respectively; DARR mixing time,
24 ms; number of acquisition, 64 for each FID; and ωR=12.5 kHz. The
spectrum is composed of contours with S/N N2.3.
Table 1
Chemical shifts of 13C and 15N signals of membrane-bound PACAP21
a.a. NH C′ Cα Cβ Cγ Cδ others
1H 32 [174±2] 55±1 32±1.3 131
2S 112 173±1.5 56±2 66±1.5
3D [174±2] 53±2.5 45±2 178
4G 108 171±2 45±1
5I 120 [174±2] 59±1.5 42±1 29/18 14
6F 126 [174±2] 56±2 44±2 133 [133] ζ 128
7T [174±2] 59.6±1.5 71±1.5 22
8D 122 [174±2] 53±2 45±2 178
9S 112 173±1.5 56±2 66±1.5
10Y [174±2] [55±2.5] 44±2 129 [133] ε118/ζ158
11S 112 173±1.5 56±2 66±1.5
12R [174±2] [54±1.5] 35±1.5 28 44 ζ160/Nε82
13Y [174±2] [55±2.5] 44±2 129 [133] ε118/ζ158
14R [174±2] [54±1.5] 35±1.5 28 44 ζ160/Nε82
15K [174±2] [54±1.5] [36±1.5] 26 29 ε42/Nζ30
16Q [174±2] [54±1.5] 30±2 35 179
17M [174±2] 54±1 [35±⁎Δ]
18A 175±1 51±1.3 23±1.5
19V 122 [174±2] 60.4±1.5 35±2 22
20K 126 [174±2] [54±1.5] [36±1.5] 26 28 ε42/Nζ30
21K 180±2 53±1.5 [36±1.5] 26 28 ε42/Nζ30
Italics, assignment to individual amino acid species; [ ], assignment for the
signal overlapped with those of other amino acid species; ⁎Δ=+2.5 and −4.
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determined at the first step, assuming the presence of all signals.
A 2D homonuclear 13C–13C correlation DARR spectrum of
the membrane-bound PACAP21 (lipid/peptide=36) is pre-
sented in Fig. 1. Assignment started with the BMRB database
that gives the typical chemical shifts of amino acid residues. As
shown in Fig. 1D, aliphatic carbon spin systems of Ile5, Thr7
and Val19 could be traced. Here, the numbered residues are
uniquely assigned because they are single residues in
PACAP21. Using the information from 13Ci,
15Ni-correlation
in Fig. 2A, the spin systems of Arg and Lys were also traced.
The Cα/Cβ cross peaks for Ala18 and Ser could be easily
identified at (51, 23) and (56, 66) ppm. However, the signals of
three Ser residues could not be observed separately. This is a
typical feature of the spectra obtained in this work. We can get
only bulk chemical shifts for each amino acid residue in an
intra-residue correlation spectrum. The Cβ chemical shifts of
Phe, Tyr and His were determined by Cβ/Cγ cross peaks
(Fig. 1C). The Gly4 Cα/C', Ala18 Cβ/C' and Ser Cα/C' cross
peaks could be also assigned in Fig. 1A. Signals at the lowest
field could be assigned to the side chain carboxyl groups of Asp
and carboxylamide groups of Gln16 and Lys21. Otherwise, the
carbonyl signals were assumed to be located at overlapped
peaks in Cβ/C' areas. This is reasonable because of their narrow
distributions. The cross peaks of Cζ/Cδ, Cζ/Cγ, Cζ/Cβ and
Cζ/Cα of Arg were identified at (160, 44), (160, 28), (160, 35)
and (160, 54) ppm in a DARR spectrum with 200 ms mixing
time as can be seen in Fig. 1B. There are contributions from Tyr
to the signals at 44 and 54 ppm as well.
2D heteronuclear 15N–13C spectra for intra- and inter-
residue correlations (15Ni–
13(CαCβ)i and
15Ni+1–
13(CO,
CαCβ)i, respectively) are presented in Fig. 2. From the intra-
residue correlation (Fig. 2A), Gly4 Cα/N, Lys Cε/NH3
+, Lys Cδ/
NH3
+ and Arg Cδ/Nε cross peaks were identified as isolated
peaks. Since His1 should have the terminal ammonium group,
the cross peak at (15N, 13C)=(32, 55) ppm can be ascribed to
His1 Cα/NH3
+ correlation. On the basis of Cα chemical shifts
determined and the general tendency of 15N chemical shifts inBMRB, well-defined points in the overlapped signals are
attributed to Ile5 Cα/N, Val19 Cα/N and Ser Cα/N, respec-
tively. In the inter-residue correlation spectrum (Fig. 2B),
D3CαG4N could be identified as an isolated peak. Possible
assignments are also presented in the figure on the basis of the
assignment of 13Cα, namely, I5αF6N, T7αD8N, V19αK20N
and A18αV19N in the major body of overlapping, and G4αI5N
and I5βF8N in the neighbor.
A Cαi+1–(CαCβ)i correlation spectrum of PACAP21 is
shown in Fig. 3. We could assign well resolved (CαCβ)i+1–Cαi
cross peaks to I5αF6α and M17αA18α correlation signals on
the basis of assigned chemical shifts for Ile5 Cα, Phe6 Cα and
Ala18 Cα. Therefore, Met17 Cα/Cβ should be located in the
congested region at around (54, 35) ppm. Since Cβ of Gln
appears at the highest field except for that of Ala and the
chemical shift of Met17Cα is known, the cross peak at (30, 54)
ppm was attributed to Q16βM17α. Although the Cαi+1–Cαi
correlations for D3G4, G4I5, F6T7, A18V19 and V19K20
should appear as isolated or well-defined peaks, they failed to
emerge. These cross peaks could not be observed even in lower
contour levels. The assigned chemical shifts are summarized in
Table 1. Signals only assigned to individual amino acids are
shown in italics and the assignment of a signal overlapped with
those of other amino acids is given in a parenthesis. The
uncertainty due to the line-width is given for Cα, Cβ and C′ in
the table.
Since we used a sample at a high peptide concentration, the
effect of concentration on the chemical shifts was examined
with a 10-fold diluted sample (lipid/peptide=360). 2D spectra
could not be obtained with this sample. Thus, 1D MAS/CP
13C-NMR spectra were recoded for the samples at high and
low peptide concentrations. They are compared in Fig. 4. On
Fig. 4. Effect of peptide/lipid dilution on a 1D CP/MAS 13C-NMR spectrum of
membrane-bound [U–13C, 15N] PACAP21 at 11.74 T. (A) Peptide:lipid (mol/
mol)=1:36 at 233 K, and (B) the ratio=1:360 at 223 K. The contact time, 2.2 ms
for A and B; Number of acquisition, 960 and 52000 for A and B, respectively;
and ωR =12.5 kHz. Possible amino acid residues contributing to each signal are
given by single-letter codes.
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singlet, and those at around 55 ppm got sharper. Furthermore,
those at around 43 ppm are almost gone. The diminished
signals did not recover even in the single pulse experimentFig. 5. 2D 13C–13C correlation spectra of membrane-bound [U–13C, 15N] PACAP27
time, 17 ms; number of acquisition, 64 for each FID; data matrix, 400×1024; and ω
carbon correlation (RFDR) at 233 K. Mixing time, 2.96 ms; number of acquisition,
(SPC-5) at 273 K. Double quantum dipolar mixing time, 1.25 ms; number of acquisiti
with solid lines. SSB stands for a spinning side band. (D) Aliphatic–aliphatic carb
spectrum is presented by contours with S/N N8.under proton-decoupling, which might be ascribed to the
interference between their motion and proton-decoupling.
Although the reason of the spectral change is not yet clear
at this stage, the chemical shifts of the observed signals did
not change on dilution. It can be concluded that the major part
of the membrane-bound peptide still takes on an extended
conformation under the diluted condition.
3.2. Signal assignment of PC membrane-bound PACAP27
Since PACAP27 binds to DMPC bilayers, we prepared the
sample with deuterated DMPC-d54. This sample gave a better
RFDR spectrum at 233 K and a better SPC-5 spectrum at 273 K.
RFDR spectra gave the information essentially identical with
that from SPC-5 spectra. 13C–13C correlation spectra of
membrane-bound PACAP27 are presented in Fig. 5. The
observed chemical shifts were the same within the resolution
limits at temperature from 213 to 273 K. Under these conditions,
the DMPC bilayers are in the gel state. In the double quantum
dipolar mixing spectrum, one-step magnetization transfer gave
rise to a negative intensity, colored green, and two-step
magnetization transfer gave rise to a positive intensity, colored
black. Spin connectivities of Ile, Thr, Val, Leu, and Arg could be
traced as shown in the spectrum (Fig. 5C). Although there are
two Leu Cα/Cβ cross peaks, they will be justified by later
assignment. Those of Arg, Lys, andGln16 also could be traced in
the DARR spectrum (Fig. 5D). In the case of Arg and Lys, the
chemical shifts determined by 13C,15N-correlation (Fig. 6) were
used. Cα/Cβ cross peaks of Ala and Ser were assigned from their
characteristic chemical sifts. Although the intra-residue Cα/Cβ
cross peaks of His, Arg, Lys and Met signals are overlapped,at 16.44 T. (A) Aliphatic–carbonyl carbon correlation (DARR) at 233 K. Mixing
R=16 kHz. Sensitivity is enhanced in a squared region. (B) Aliphatic–aromatic
16 for each FID; and ωR=13.5 kHz. (C) Aliphatic–aliphatic carbon correlation
on, 64 for each FID; and ωR=16 kHz. The side-chain connectivity was indicated
on correlation (DARR) at 233K. The parameters are same to those of A. The
Fig. 6. 2D intra- and inter-residue 15N–13C correlation spectra of membrane-bound [U–13C, 15N] PACAP27 at 11.74 T and 273 K. (A) Intra-residue correlation.
Contact time from Ni to Ci, 7 ms; number of acquisition, 64 for each FID; data matrix, 320×270; and ωR=12.5 kHz. (B) Inter-residue correlation. Contact time from
Ni+1 to C'i, 5 ms; RFDR mixing time, 2.24 ms; number of acquisition, 128 for each FID; data matrix, 320×400; and ωR=12.5 kHz. Sensitivity is enhanced in a
squared region.
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will be described later. The Cβ chemical shifts of Phe, Tyr and
His are determined using their Cβ/Cγ cross peaks (Fig. 5B).
His1 Cβ/Cγ was very weak. In the case of Tyr, however, two
Cα/Cβ cross peaks were assigned. At first, it was assigned to
(56, 43) ppm from themajor intensity of the Cβ/Cγ cross peak as
in the case of Phe6. Since a weak cross peak at (53, 41) ppm was
remained unassigned at the final stage of the assignment, this
was tentatively assigned to Tyr in view of the Cβ chemical shift.
In Fig. 5A, Gly4 Cα/C', Ala Cβ/C', Thr7 Cβ/C', Ser Cβ/C',
Ile5 Cα/C' and Val Cα/C' could be assigned. Furthermore,
signals at the lowest field could be assigned to the side chain
carboxyl groups of Asp and carboxylamide groups of Gln16 and
Leu27. Otherwise, the peak tops were interpreted as the
overlapped carbonyl signals in Cβ/C' areas as in the case of
PACAP21.
A 2D intra-residue 15N–13C correlation spectrum of
PACAP27 is presented in Fig. 6A. The 15N chemical shifts
can be specified from the 13C chemical shifts of isolated cross
peaks. The His1 Cα/N, Gly4 Cα/N, Ala Cβ/N, Lys Cε/Nζ, Lys
Cδ/Nζ, Arg Cδ/Nε and Arg Cγ/Nε cross peaks could be easily
identified. His1 signal was observed as two peaks, suggesting
that the N-terminus takes two conformations. On the basis of the
carbon chemical shifts, Val Cα/N could be assigned as well. The
inter-residue 15Ni+1–
13(CO, CαCβ)i correlation spectrum(Fig. 6B) provides more information. The cross peaks of
D3Cα/G4N, D3Cβ/G4N and L27C'/NH2 could be easily as-
signed because of well-distinguished 15N chemical shifts. In the
Ala cross peak, there are evidently two kinds of signals, which
were assigned to two AiCβ/Vi+1N and A24Cβ/A25N, respec-
tively, on the basis of their intensity. Otherwise, indicated in the
spectrum are the cross peaks that were assigned on the basis of
carbon and nitrogen chemical shifts so far obtained.
A Cαi+1–Cαi correlation spectrum of the membrane-bound
PACAP27 shown in Fig. 7 provided further information for
Cα. In contrast to PACAP21, isolated and peripheral cross
peaks are well defined except for D3G4. Thus, we can make a
sequential walking using the chemical shifts assigned so far. In
the N-terminal region, the walking starts from well-defined
cross peaks, namely, G4/I5, F6/T7, and T7/D8. I5/F6 can be
identified from G4/I5 and F6/T7. Since we know the chemical
shifts of His1 and Asp3, the walking can be extended to the
N-terminus by use of the bulk chemical shift of Ser. The cross
peakM17/A18 can be assigned on the basis of Ala chemical shift
as in the case of PACAP21. Since the chemical shift of Gln16 is
known, we can walk from Gln16 to the C-terminus on the basis
of the well-defined cross-peaks, A18/V19, V19/K20, L23/A24,
A24/A25, A25/V26, and V26/L27, provided that the chemical
shifts of Lys21 and Tyr22 are known. Note that the chemical
shifts of Lys20 and Ala25 are different from the bulk value of
Table 2
Chemical shifts of 13C and 15N signals of membrane-bound PACAP27
a.a. NH C' Cα Cβ Cγ Cδ Others
1H 38 [174±2] 55.6/54±1.5 30±1 130
2S 173±1.5 56±1.5 66±2
3D 122 [174±2] 53±1.5 46±2 178
4G 105 171±1 46±1.5
5I [124] [175±1.7] 59.5±1 42±2 28/18 15
6F [122] [174±2] 56±2.5 43±1.5 133 [132] ζ 130
7T 112 170±1 59.5±1 72±1 19.5
8D [174±2] 53±1.5 46±2 178
9S 173±1.5 56±1.5 66±2
10Y [122] [174±2] 56±1.5 43±2 129 [132] ε117/ζ158
11S [115] 173±1.5 56±1.5 66±2
12R [122] [174±2] [55±1.5] 34±2 29.5 43.5 ζ160/Nε85
13Y [174±2] 53±1.5 41±1.5 129 [132] ε117/ζ158
14R [174±2] [55±1.5] 34±2 29.5 43.5 ζ160/Nε85
15K [174±2] [55±1.5] 36±2 27 30 ε42/Nζ32
16Q [174±2] 55±1.3 29±2 35 179
17M [174±2] 54±1.5 [35±2]
18A 122 175.6±1 51±1.5 24±1.5
19V [120] [175±1.7] 59.5±1 35±1.5 21
20K [125] [174±2] 54.5±2 37±1 27 30 ε42/Nζ32
21K [125] [174±2] [55±2] 36±2 27 30 ε42/Nζ32
22Y [174±2] [56±1.5] 43±2 129 [132] ε117/ζ158
23L [174±2] 53±2 46±2 28
24A 122 175.6±1 51±1.5 23±1.5
25A 125 175.6±1 50±1.5 24±1.5
26V [120] [175±1.7] 60±1 35±1.5 21
27L [125] 181±2 55±2 41±1.5 28 NH2 107
Italics, assignment to individual amino acid species; [ ], assignment for the
signal overlapped with those of other amino acid species.
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for Tyr22, namely, 53 and 56 ppm. In the case of the former,
Y22/L23 should appear on the diagonal line. Since there is no
signal intensity in the expected region in Fig. 7, the chemical
shift of Tyr22 was assigned to 56 ppm. The bulk shift (55 ppm)
was used for Lys21. From Ser9 to Lys15, the walking was
carried out using bulk chemical shifts of Ser, Lys and Arg
because of serious overlapping of the cross peaks. There are two
possibilities for Tyr residues as in the case of Tyr22. If Tyr10 is
assigned to 53 ppm, the intensity in the central region cannot be
explained. In contrast, Tyr13 fits to 53 ppm. Therefore, Tyr10
and Tyr13 are assigned to 56 and 53 ppm, respectively. Now, the
walking from the N- to C-termini is accomplished. This walking
not only confirm the observed chemical shifts, but also provided
more exact chemical shifts for some signals. Assigned chemical
shifts of PACAP27 are summarized in Table 2 in the sameway as
for PACAP21.
3.3. Selective polarization transfer from PACAP to membranes
To confirm the binding of the PACAP peptide to phospho-
lipid membranes, the polarization transfer from the proton spins
of the PACAP27 to 2H/31P one of membranes was measured.
COXSHD spectra of the membrane-bound PACAP27 for
1H–31P and 1H–2H transfer are presented in Fig. 8A and B,
respectively. To make the cross polarization efficient, the mea-
surement was carried out at 193 K. In Fig. 8A, the polarization
transfer was observed for Tyr, Phe, His, Ser Cβ, Thr Cβ, some
of Cα and side chains of Ile, Leu, Asp, Lys and Arg. This
reveals that PACAP27 actually binds to phospholipid bilayers.
Since phosphate groups are located on the surface of phos-Fig. 7. A 2D 13Cαi–
13Cαi+1 correlation spectrum of membrane-bound [U–
13C,
15N] PACAP27 at 11.74 Tand 213 K. Contact times from Cαi+1 to Ni+1 and from
Ni+1 to C'i, 2.5 and 4 ms, respectively; DARR mixing time, 24 ms; number of
acquisition, 64 for each FID; data matrix, 400×1024; and ωR=12.5 kHz.
Sequential assignment of Cα is indicated by solid lines. The dashed line shows
the connection of D3G4. The spectrum is composed of contours with S/N N2.3.pholipid membranes, the peptide should lay on the membrane
surface. The polarization transfer from the protons to the
deuterons of fatty acids provides the information about the
amino acid residues interacting with the hydrophobic region of
the membrane. In Fig. 8B, the transfer was also observed for
aliphatic carbons and aromatic carbons. However, the pattern is
different from that in Fig. 8A. Especially, the transfer was
mainly observed for Phe in the aromatic region, judged from the
weak HY signal. This indicates that the side chain of Phe is
inserted into the hydrophobic region, while those of His and Tyr
stay in the surface region. In the aliphatic region, the po-
larization was observed mainly for Cβ and Cγ of Ile, Leu and
Val, and Cβ of Ala and Phe. This fact shows that PACAP27 is
localized on the membrane surface with the hydrophobic side
chains being inserted into the inner region of the membrane.
Since Ala, Leu and Val are the residues in the C-terminal region
of PACAP27, the C-terminal hydrophobic region plays an
important role in binding to the membrane.
4. Discussion
4.1. Secondary structural analysis of PACAP21 and PACAP27
The spectral sensitivity and resolution was better for
PACAP27 than for PACAP21, which may be attributed to
differences in the phospholipid composition and the rotor size.
Because of broad line-widths, the sequentially assigned signals
were 10/21Cα, 8/20Cβ and 3/21C' for PACAP21, and 17/27Cα,
Fig. 8. 1D 31P/2H-selective 1H-depolarization 13C-NMR (COXSHD) spectra of membrane-bound [U–13C, 15N] PACAP27. (A) 31P–1H–13C polarization transfer, and
(B) 2H–1H–13C polarization transfer. Amino acid residues which may contribute to each signal are indicated by single-letter codes.
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was within±2 ppm for most signals. For isolated peaks of
single residues, the line-width is 2–3 ppm. Since the contribution
of line-broadening factor is 0.8 ppm, the intrinsic line-width
should be 1.2–2.2 ppm. The 13C linewidth of 1.5–2 ppm at 11.74
was reported to be a typically well-structured and rigid non-
crystalline peptide, while a disordered structure gives a 4–5 ppm
[35]. Therefore, PACAP21 and PACAP27 should take a relatively
well-defined structure.
We have calculated the main chain φ and ψ angles with the
program TALOS version 2003.027.13.05, using 13Cα, 13Cβ,
and 13C' chemical shifts [36]. Predicted φ and ψ angles are
plotted in red in Fig. 9. The classification was “good“ for all
residues except Gly4. In view of the broad line-widths, the
effect of the uncertainty on the prediction of dihedral angles was
checked. The dihedral angles were calculated for the chemical
shifts δαi +Δδαi and δβi−Δδβi, where Δδ is the uncertainty
shown in Tables 1 and 2. This gives the largest change favorable
for a helical conformation. Nevertheless, the obtained angles are
favorable for extended conformations in spite of two unreliable
angle pairs (Fig. 9, in green). Calculations for the chemical
shifts δαi−Δδαi and δβi +Δδβi were also carried out, which
gave the angles favorable for extended conformations (Fig. 9, in
blue). This result indicates that backbone dihedral angles of
membrane-bound PACAP21 and PACAP27 fit to extended
conformations. Then, the chemical shifts were calculated for all
extended conformations with SHIFTX. They matched theobserved chemical shifts except Gly4. Therefore, we have
concluded that both PACAP21 and PACAP27 take on the
extended conformation on binding to lipid membranes in the gel
state, although there could be a distortion around Gly4.
4.2. Comparison of the obtained conformations with those of
PACAP27 in micelles and PACAP21 bound to the receptor
The reported structure of the DPC micelle-bound PACAP27
comprises a long α-helix (residues 5–27) flanked by a dis-
ordered N-terminal tail (residues 1–4) [16]. This is different
from the extended conformation of the membrane-bound
PACAP27 determined in this work. Therefore, carbon chemical
shifts were calculated with SHIFTX [37] for all α-helix structure
of PACAP27 and mapped on a 13C–13C correlation spectrum of
DMPCmembrane-bound PACAP27. The calculated cross peaks
did not match the observed one (data not shown), confirming
that the secondary structure of membrane-bound PACAP27 is
different from the conformation in DPC micelles.
A 2D 13C–13C DARR spectrum of PACAP21 with a mixing
time 500 ms was observed to detect relatively long-range
distances (∼6.5 Å). It is presented in Fig. 10. A well-separated
peak at (46, 60) ppm could be assigned to either G4Cα/T7Cα or
G4Cα/V19Cα correlation. One possibility is that G4T7
correlation is caused by bending of peptide as in the case of
the receptor-bound PACAP21 [16]. However, the predicted
dihedral angles in Fig. 9 contradict this idea. So, this correlation
Fig. 10. A 2D 13C–13C correlation DARR spectrum of membrane-bound
[U–13C, 15N] PACAP21 at 11.74 T and at 233 K. Mixing time, 500 ms; number
of acquisition, 64 for each FID; data matrix, 400×1024; and ωR=12.5 kHz.
Fig. 9. Backbone dihedral angles ϕ and ψ predicted with TALOS as a function
of residue number. (A), PACAP21; (B), PACAP27. The chemical shifts of Cα,
Cβ and C' in Tables 1 and 2 were used for calculation. Symbols; red triangle, for
observed chemical shifts (δi); green circle, for δαi +Δδαi and δβi−Δδβi; and
blue square, for δαi−Δδαi and δβi +Δδβi. The error bars indicate RMSD for
the predicted dihedral angles. Angles with less than 7 reliable pairs are omitted.
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region of His1–Tyr10 takes on an antiparallel β-sheet that
brings Gly4 and Thr7 close to each other, Asp3 and Asp8 line
up side by side. This would be unstable on the membranes with
net negative charges. Therefore, a possible structure is an anti-
parallel β-sheet formed by the peptide region from Ser2 to
Lys21 that brings Gly4 and Val19 close to each other.
4.3. Conformational characteristics of PACAP27 and PACAP21
bound to the membranes
Although the overall conformation is the same for
PACAP21 and PACAP27, the binding mechanism is different.
While the former cannot bind to PC membranes, the latter can.
The side chains of the hydrophobic residues of PACAP27 were
shown to be involved in the binding. Therefore, the nature of
the binding for the former and latter should be electrostatic and
hydrophobic interactions, respectively. In the measurement of
Cαi+1–(CαCβ)i correlation of PACAP21, the cross peaks of
D3G4, G4I5, F6T7, A18V19 and V19K20 could not be ob-
served in the expected regions. Although we do not have the
information on H1S2 and S2D3 because of their localization in
the congested region, it is strongly suggested that the N-terminal
region is relatively flexible even at 223 K because of the soft
interaction on the membrane surface. Since the pulse sequence
of the Cαi+1–(CαCβ)i correlation includes three cross polariza-
tions, mobility makes the total polarization transfer inefficient.
Since D3G4 cross peak could not be observed and the intensityof G4I5 was very weak, the N-terminal region (His1–Ile5)
seems to be flexible also for PACAP27. The extended structures
for PACAP21 and PACAP27 reveal that it cannot be ascribed to
the nature of peptide–membrane interactions. Furthermore, the
dilution of PACAP21 did not change the extended conformation
as shown above. The sharp signals strongly suggest that the
peptide takes on a well-defined structure in monomers or small
oligomers, showing that a high concentration of the peptide is
not responsible for the extended structure formation. Therefore,
it can be concluded that the interaction of PACAP peptides with
the membrane surface causes their extended conformation,
which should be ascribed to its amino acid sequence.
A possible origin of the extended conformations for
PACAP21 and PACAP27 is fibril formation induced by lipid
bilayers. The fibril formation usually needs a certain time for
nucleation and elongation. In the case of monosialoganglioside
GM1-induced fibril formation, it took 12–20 h [38]. However,
PACAP21 and PACAP27 bind liposomes instantly. Further-
more, a dilution of the peptide did not change the conformation.
Therefore, a huge fibril formation is not likely, although a short
fibril formation on the membrane cannot be eliminated at this
stage. Furthermore, we cannot rule out the possibility that
PACAP becomes a monomer only at very low concentration,
and the monomer takes on an α-helical conformation.
4.4. Biological significance of the variable conformation for
PACAP27
The structure of micelle-bound PACAP27 comprises a long
α-helix (residues 5–27) and a disordered N-terminal tail
(residues 1–4) [16]. In the case of the receptor-bound
PACAP21 structure, however, there are an extended N-terminal
tail (residues 1–2), a consecutive β-turns (residues 3–7) and an
α-helix (residues 8–21) [16]. An N-terminally truncated
PACAP38 (residues 6–38) takes on α-helix in the receptor
[17]. In these cases, the α-helix is the major secondary structure.
Therefore, this peptide changes its conformation depending on
its environment or interacting partners. Usually, a conformation
in micelles is also realized in membranes. However, this is not
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bound peptides reported so far take on α-helices [19,21]. This is
also not the case with PACAP27. Therefore, we can conclude
that this hormone peptide has a unique conformational property.
A conformational change on membranes was suggested for
fusogenic peptide B18, related viral fusogenic peptides [39] and
an amyloid precursor protein Aβ(1–40) [38,40]. B18 takes on
α-helix under lipid/peptide N100, and β-sheets at a higher
peptide concentration, which induce membrane-fusion. Aβ(1–
40) takes on helix-rich conformations when it binds to
monosialoganglioside GM1 bilayers, then forms amyloid fibrils
after 12–20 h. These are also the examples that peptides can
change their conformations depending on their environments.
It has been indicated that the N-terminal residues are im-
portant for the receptor recognition and C-terminal residues
facilitate the binding ability. Actually, the deletion of His1–
Ile5 caused 200-fold reduction in the binding affinity [41]. The
N-terminal regions of both PACAP27 and PACAP21 were
shown flexible even on the membrane surface in this work. In
contrast, the C-terminal region of PACAP27 was shown to be
involved in the membrane binding in the polarization transfer
experiment. These properties would be important for PACAP27
to bind the receptor and exert an induced fit on it, provided that
membranes are involved in the receptor binding. PACAP27 is
known to work in various sites in a wide variety of tissues. Its
conformational flexibility may be associated with the variable
roles in different places. Actually, an N-terminally truncated
neurotensin (residues 8–13) was reported to take on aβ-strand in
its G-protein coupled receptor bound form [42].
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